• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 3. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615

Professional Introduction to Benzyl N-[trans-4-aminocyclohexyl]carbamate hydrochloride (CAS No. 1217664-37-3)

Benzyl N-[trans-4-aminocyclohexyl]carbamate hydrochloride (CAS No. 1217664-37-3) is a specialized chemical compound that has garnered significant attention in the field of pharmaceutical research and development. This compound, characterized by its unique structural and functional properties, is being explored for its potential applications in various therapeutic areas. The combination of a benzyl group, a carbamate moiety, and a trans-4-aminocyclohexyl side chain imparts distinct biochemical characteristics that make it a subject of interest for medicinal chemists and pharmacologists.

Thebenzyl group in the molecular structure contributes to the compound's solubility and stability, while thecarbamate moiety plays a crucial role in its reactivity and interaction with biological targets. Thetrans-4-aminocyclohexyl side chain adds to the compound's complexity, influencing its pharmacokinetic profile and potential therapeutic effects. These structural features collectively makeBenzyl N-[trans-4-aminocyclohexyl]carbamate hydrochloride a promising candidate for further investigation.

In recent years, there has been growing interest in the development of novel compounds that can modulate biological pathways associated with neurological disorders, inflammation, and pain management. TheN-[trans-4-aminocyclohexyl]carbamate moiety has shown particular promise in this context, as it can interact with specific enzymes and receptors involved in these pathways. For instance, studies have indicated that derivatives of this structure may have potential applications in the treatment of chronic pain conditions by acting on neurotransmitter systems.

The hydrochloride salt form of this compound enhances its bioavailability and solubility, making it more suitable for pharmaceutical formulations. This form is particularly advantageous for oral administration, where rapid absorption and distribution are critical for achieving therapeutic effects. The stability of the hydrochloride salt also ensures that the compound remains effective during storage and transportation.

Recent research has begun to explore thebenzyl N-[trans-4-aminocyclohexyl]carbamate hydrochloride's potential in oncology. Preliminary studies suggest that this compound may exhibit inhibitory effects on certain kinases involved in cancer cell proliferation. By targeting these kinases, the compound could potentially disrupt signaling pathways that are crucial for tumor growth and survival. While these findings are still in the early stages of investigation, they highlight the compound's versatility and its potential as a lead molecule for further drug development.

TheCAS No. 1217664-37-3 identifier is essential for distinguishing this compound from other molecules with similar structures or functionalities. This unique numerical code ensures accurate documentation, classification, and regulatory compliance throughout its lifecycle. Researchers and regulatory agencies rely on such identifiers to maintain consistency and precision in their work.

The synthesis ofBenzyl N-[trans-4-aminocyclohexyl]carbamate hydrochloride involves multi-step organic reactions that require careful optimization to achieve high yields and purity. Advanced synthetic techniques, such as catalytic hydrogenation and protecting group strategies, are often employed to construct the complex molecular framework efficiently. The final product must undergo rigorous analytical testing to confirm its identity and quality before it can be used in preclinical or clinical studies.

In conclusion, Benzyl N-[trans-4-aminocyclohexyl]carbamate hydrochloride (CAS No. 1217664-37-3) represents a significant advancement in pharmaceutical chemistry due to its unique structural features and potential therapeutic applications. Its ability to interact with biological targets associated with various diseases makes it a valuable asset in drug discovery efforts. As research continues to uncover new insights into its mechanisms of action, this compound is poised to play an important role in the development of next-generation therapeutics.

• 1179361-50-2(Benzyl (4-aminocyclohexyl)carbamate hydrochloride)
• 227017-99-4(Carbamic acid, (4-aminocyclohexyl)-, phenylmethyl ester (9CI))
• 149423-70-1(Benzyl cis-4-aminocyclohexylcarbamate)
• 149423-77-8(trans-4-(Benzyloxycarbonylamino)cyclohexylamine)
• 1223158-00-6(Benzyl (trans-3-aminocyclohexyl)carbamate)
• 1222709-28-5(Benzyl trans-3-aminocyclohexylcarbamatehydrochloride)
• 1353971-24-0((4-Methylamino-cyclohexyl)-carbamic acid benzyl ester)
• 7107-58-6(Carbamic acid, cyclohexyl-, phenylmethyl ester)
• 1131622-27-9(Benzyl (1-amino-3-pentanyl)carbamate)
• 1261225-45-9(Benzyl N-(1S,3R)-3-Aminocyclohexylcarbamate)